University of Montreal: RESTART Trial - Drug to Block a Toxic HIV Molecule
October 02, 2025
October 02, 2025
MONTREAL, Quebec, Oct. 2 (TNSjou) -- The University of Montreal issued the following news:
* * *
The RESTART trial: a drug to block a toxic HIV molecule
Combined with regular antiretroviral therapy, could fostemsavir have beneficial effects on the cardiovascular health of people living with HIV? CRCHUM researchers investigate.
By Bruno Geoffroy
What if the presence of a well-known but misunderstood viral protein explains why some . . .
* * *
The RESTART trial: a drug to block a toxic HIV molecule
Combined with regular antiretroviral therapy, could fostemsavir have beneficial effects on the cardiovascular health of people living with HIV? CRCHUM researchers investigate.
By Bruno Geoffroy
What if the presence of a well-known but misunderstood viral protein explains why some . . .